A Democratic bill with 1 Republican cosponsor · See all 2 cosponsors
Last activity — Read twice and referred to the Committee on the Judiciary.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The "Freedom to Heal Act of 2025" aims to create a special registration process under the Controlled Substances Act. This allows physicians to directly administer schedule I eligible investigational drugs to patients under the Federal Right to Try law. The Attorney General is tasked with managing this registration process. Physicians must meet specific requirements, including providing evidence of valid registration for other substances and compliance with existing laws. The bill also outlines how physicians can request additional amounts of drugs and how they can use a single registration for multiple related sites. Finally, it mandates the creation of specific rules regarding the delivery, storage, and security of these drugs.
Yes
- Scored +7
Does this make health care easier to get in general?
The bill expands access to investigational drugs for eligible patients through a new registration process for physicians.
- Scored +1
Would people with disabilities be better off under this?
The bill may benefit patients with severe conditions who are eligible for Right to Try protocols.
The opposite
- Scored -2
Does this make what the government does easier for the public to see?
The bill grants the Attorney General significant administrative authority over the registration and security of drug distribution.
Who it would affect, and how
Potential Positive Impacts for People
-
Access to investigational drugs: The bill allows physicians to directly administer schedule I eligible investigational drugs to eligible patients under the Federal Right to Try law (Section 2, paragraph 2).
-
Streamlined registration for multiple locations: Physicians can use a single registration to treat patients across multiple sites if those sites are within the same city or county and under the same control (Section 2, paragraph 6).
-
Flexibility in drug supply: Physicians have a mechanism to request additional quantities of a drug through a supplemental notification process (Section 2, paragraph 5).
Potential Negative Impacts for People
-
Strict application requirements: Physicians face a heavy burden of proof, needing to provide evidence of valid registrations for other substances, compliance documentation from manufacturers, and proof that they can treat patients under state laws (Section 2, paragraph 3).
-
Regulatory oversight and potential for investigation: The Attorney General has the authority to serve an "order to show cause" upon applicants during both the initial registration and supplemental notification processes (Section 2, paragraph 3 and paragraph 5).
-
Limitations on drug possession: Physicians are restricted to possessing only the amounts of the drug identified in their initial application or their supplemental notifications (Section 2, paragraph 5).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Healthcare
- Does this make health care easier to get in general? — The bill expands access to investigational drugs for eligible patients through a new registration process for physicians.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill grants the Attorney General significant administrative authority over the registration and security of drug distribution.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — The bill may benefit patients with severe conditions who are eligible for Right to Try protocols.
- 2/11/2026
- 1 Cosponsor added.
- 12/4/2025
- Read twice and referred to the Committee on the Judiciary.
- 1 Cosponsor added.
- Introduced in Senate
2 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Martin HeinrichDemocrat · New Mexico
Rand PaulRepublican · Kentucky